Cargando…

Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy

Metachromatic leukodystrophy (MLD) is a lysosomal storage disease resulting from a deficiency of arylsulfatase A causing an accumulation of cerebroside sulfate, a lipid normally abundant in myelin. Sulfatide accumulation is associated with progressive demyelination and a clinical presentation in sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Thibert, Kathryn A., Raymond, Gerald V., Tolar, Jakub, Miller, Weston P., Orchard, Paul J., Lund, Troy C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832325/
https://www.ncbi.nlm.nih.gov/pubmed/27079147
http://dx.doi.org/10.1038/srep24579
_version_ 1782427235386392576
author Thibert, Kathryn A.
Raymond, Gerald V.
Tolar, Jakub
Miller, Weston P.
Orchard, Paul J.
Lund, Troy C.
author_facet Thibert, Kathryn A.
Raymond, Gerald V.
Tolar, Jakub
Miller, Weston P.
Orchard, Paul J.
Lund, Troy C.
author_sort Thibert, Kathryn A.
collection PubMed
description Metachromatic leukodystrophy (MLD) is a lysosomal storage disease resulting from a deficiency of arylsulfatase A causing an accumulation of cerebroside sulfate, a lipid normally abundant in myelin. Sulfatide accumulation is associated with progressive demyelination and a clinical presentation in severe disease forms that is dominated by motor manifestations. Cerebral inflammation may contribute to the pathophysiology of MLD. To date, cytokine levels in the cerebral spinal fluid of MLD patients have not previously been reported. The objective of this study was to evaluate the concentration of inflammatory cytokines in the CSF of patients with MLD and to compare these levels to unaffected controls. Of 22 cytokines evaluated, we documented significant elevations of MCP-1, IL-1Ra, IL-8, MIP-1b and VEGF in the MLD patients compared to unaffected controls. The elevated cytokines identified in this study may play a significant role in the pathophysiology of MLD. Better understanding of the inflammatory and neurodegenerative process of MLD may lead to improved targeted therapies.
format Online
Article
Text
id pubmed-4832325
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48323252016-04-20 Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy Thibert, Kathryn A. Raymond, Gerald V. Tolar, Jakub Miller, Weston P. Orchard, Paul J. Lund, Troy C. Sci Rep Article Metachromatic leukodystrophy (MLD) is a lysosomal storage disease resulting from a deficiency of arylsulfatase A causing an accumulation of cerebroside sulfate, a lipid normally abundant in myelin. Sulfatide accumulation is associated with progressive demyelination and a clinical presentation in severe disease forms that is dominated by motor manifestations. Cerebral inflammation may contribute to the pathophysiology of MLD. To date, cytokine levels in the cerebral spinal fluid of MLD patients have not previously been reported. The objective of this study was to evaluate the concentration of inflammatory cytokines in the CSF of patients with MLD and to compare these levels to unaffected controls. Of 22 cytokines evaluated, we documented significant elevations of MCP-1, IL-1Ra, IL-8, MIP-1b and VEGF in the MLD patients compared to unaffected controls. The elevated cytokines identified in this study may play a significant role in the pathophysiology of MLD. Better understanding of the inflammatory and neurodegenerative process of MLD may lead to improved targeted therapies. Nature Publishing Group 2016-04-15 /pmc/articles/PMC4832325/ /pubmed/27079147 http://dx.doi.org/10.1038/srep24579 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Thibert, Kathryn A.
Raymond, Gerald V.
Tolar, Jakub
Miller, Weston P.
Orchard, Paul J.
Lund, Troy C.
Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy
title Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy
title_full Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy
title_fullStr Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy
title_full_unstemmed Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy
title_short Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy
title_sort cerebral spinal fluid levels of cytokines are elevated in patients with metachromatic leukodystrophy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832325/
https://www.ncbi.nlm.nih.gov/pubmed/27079147
http://dx.doi.org/10.1038/srep24579
work_keys_str_mv AT thibertkathryna cerebralspinalfluidlevelsofcytokinesareelevatedinpatientswithmetachromaticleukodystrophy
AT raymondgeraldv cerebralspinalfluidlevelsofcytokinesareelevatedinpatientswithmetachromaticleukodystrophy
AT tolarjakub cerebralspinalfluidlevelsofcytokinesareelevatedinpatientswithmetachromaticleukodystrophy
AT millerwestonp cerebralspinalfluidlevelsofcytokinesareelevatedinpatientswithmetachromaticleukodystrophy
AT orchardpaulj cerebralspinalfluidlevelsofcytokinesareelevatedinpatientswithmetachromaticleukodystrophy
AT lundtroyc cerebralspinalfluidlevelsofcytokinesareelevatedinpatientswithmetachromaticleukodystrophy